IPAB sets aside Sutent patent rejection
07-06-2013
India’s Patent Office has revoked pharmaceutical company Sugen and licensee Pfizer’s patent for the cancer drug Sutent, agreeing with Indian drugs maker Cipla that it lacks inventive step.
If you have already subscribed please login.
If you have any technical issues please email tech support.
India, Patent Office, Pfizer, Sugen, Sutent, Cipla
